Back
Perspective Therapeutics Vs. Stride Industry Stock Comparison
Sell
30
CATX
Perspective Therapeutics
Last Price:
12.13
Seasonality Move:
11.55%
Sell
28
LRN
Stride
Last Price:
65.65
Seasonality Move:
-5.04%
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $13.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Stride (LRN)
is a Sell
Is Stride a Buy, Sell or Hold?
- The current Stride [LRN] share price is $64.04. The Score for LRN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- LRN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $13.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
LRN Stock Price Chart
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 47.65 | Sell |
Chaikin Money Flow: | 430326 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.29 - 13.93) | Sell |
Bollinger Bands (100): | (11.4 - 14.56) | Buy |
LRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.24 | Sell |
Relative Strength Index (14 RSI): | 15.91 | Sell |
Chaikin Money Flow: | -4955842 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (74.28 - 85.6) | Sell |
Bollinger Bands (100): | (68.94 - 81.36) | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.9 | Buy |
20-day SMA: | 12.86 | Buy |
50-day SMA: | 13.78 | Sell |
200-day SMA: | 12.19 | Buy |
8-day EMA: | 12.84 | Buy |
20-day EMA: | 13.09 | Sell |
50-day EMA: | 13.36 | Sell |
200-day EMA: | 11.73 | Buy |
LRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.65 | Sell |
20-day SMA: | 79.41 | Sell |
50-day SMA: | 80.38 | Sell |
200-day SMA: | 68.69 | Sell |
8-day EMA: | 72.1 | Sell |
20-day EMA: | 76.64 | Sell |
50-day EMA: | 77.91 | Sell |
200-day EMA: | 69.35 | Sell |
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
Stride Earnings Growth & LRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $0.44 per share.
Perspective Therapeutics Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Stride Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |